ADALIMUMAB-AQVH

99 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking ADALIMUMAB-AQVH:

# Side effect Count
0 ACCIDENTAL EXPOSURE TO PRODUCT 34
1 PRODUCT DOSE OMISSION ISSUE 31
2 DEVICE MALFUNCTION 28
3 NO ADVERSE EVENT 15
4 DEVICE LEAKAGE 11
5 PRODUCT QUALITY ISSUE 9
6 PRODUCT COMPLAINT 6
7 DRUG INEFFECTIVE 5
8 DEVICE FAILURE 4
9 DEVICE ISSUE 4
See all common reactions for ADALIMUMAB-AQVH

ADALIMUMAB-AQVH is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUBACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY 1 0.0294
1 ACNE FULMINANS 1 0.0051
2 FAILURE TO SUSPEND MEDICATION 1 0.0048
3 POLYCHONDRITIS 1 0.0024
4 DEVICE SAFETY FEATURE ISSUE 2 0.0020
5 RETINAL VASCULAR DISORDER 1 0.0017
6 SITTING DISABILITY 1 0.0016
7 GLOMERULONEPHRITIS MINIMAL LESION 1 0.0014
8 MALIGNANT ASCITES 1 0.0013
9 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
See all enriched reactions for ADALIMUMAB-AQVH